Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.
Fiche publication
Date publication
septembre 2023
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PETIT Jean-Michel, Pr MANFREDI Sylvain, Dr ROSSI Cédric
Tous les auteurs :
Paris J, Legris P, Devaux M, Bost S, Gueneau P, Rossi C, Manfredi S, Bouillet B, Petit JM, Pistre P, Boulin M
Lien Pubmed
Résumé
Diabetes negatively impacts cancer prognosis. The objective of this work was to evaluate a tripartite oncologist-pharmacist-diabetologist collaboration in the management of patients with diabetes starting chemotherapy.
Mots clés
cancer, diabetes, diabetologist, medication optimization, pharmacist
Référence
Cancers (Basel). 2023 09 13;15(18):